AVEIR leadless pacemaker UK registry study

This trial tests a new pacemaker system for people who need a pacemaker for a slow or irregular heartbeat. It aims to see if the system is safe and works well.

This study looks at how well a new type of pacemaker, called Aveir AR, works for people with Medicare. It helps doctors understand if this leadless pacemaker is safe and effective for treating slow heart rhythms.

This study uses your medical records from Medicare to learn how the Aveir DR leadless pacemaker performs in everyday life after it’s implanted. It mainly helps researchers and doctors understand real-world outcomes and care needs.

This trial is testing a new type of single-chamber pacemaker (called ALPs) for people who need a pacemaker due to a slow heart rate (heart block), often with atrial fibrillation. It's a leadless device that is placed directly inside the heart, avoiding the need for wires.

This study looks at Medicare claims to understand how well different pacemakers work in real-world care after they are implanted. You may be included if you are a Medicare patient who received an Aveir VR leadless pacemaker or a single-chamber ventricular pacemaker after the study began.

This study follows Medicare patients who recently got a specific type of pacemaker to see how coverage works in real life. It may help ensure patients continue to have access to the devices and care they need.